Zdrowie i gospodarka · 05/11/2014
FDA Requests Public Comment on Proposed Collection of Information for Investigational New Drug Applications
The Food and Drug Administration (FDA) is seeking public input on proposed regulations for clinical investigations of unapproved new drugs and biological products, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →